V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005197 | 320003558 | 0 | null | Palliative (P) | 2016-03-28 | 2016-05-20 | Cetuximab 7 day (>Cycle 2) | N | N | 320016072 | CETUXIMAB |
| 320005198 | 320003559 | 1.61 | 81 | Adjuvant (A) | 2015-05-22 | 2015-06-12 | Carboplatin + Liposomal Doxorubicin | N | N | 320016094 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005199 | 320003560 | 1.79 | 79.7 | Adjuvant (A) | 2017-11-20 | 2018-02-09 | Cisplatin | N | N | 320016114 | CISPLATIN |
| 320005200 | 320003560 | 1.7 | 77.7 | Curative (C) | null | 2014-09-15 | Trial Unspecified | N | N | 320016114 | TRIAL |
| 320005201 | 320003561 | 1.72 | 57.2 | Curative (C) | 2015-12-13 | 2016-01-13 | Cisplatin + Radiotherapy | N | N | 320016123 | CISPLATIN + RT |
| 320005202 | 320003562 | 1.6 | 44.6 | null | 2013-12-19 | 2014-01-18 | Liposomal Doxorubicin (Caelyx) | N | Y | 320016131 | LIPOSOMAL DOXORUBICIN |
| 320005203 | 320005619 | 1.64 | -1 | Neo-adjuvant (N) | 2016-08-29 | 2016-08-29 | null | N | N | 320016154 | NOT MATCHED |
| 320005204 | 320006604 | null | 75.6 | null | 2014-10-12 | 2014-11-10 | CISPLATIN + RT | Y | N | 320016159 | CISPLATIN + RT |
| 320005205 | 320006604 | null | 80.7 | null | 2018-08-26 | 2018-08-29 | Cisplatin | N | null | 320016159 | CISPLATIN |
| 320005206 | 320006604 | 1.66 | null | Palliative (P) | 2018-03-20 | 2018-04-06 | GEMCARBO | Y | N | 320016159 | GEMCARBO |
| 320005207 | 320003563 | 0 | 108.8 | Palliative (P) | 2013-07-18 | 2013-07-26 | CETUXIMAB | 2 | N | 320016194 | CETUXIMAB |
| 320005208 | 320003566 | 1.62 | 64.2 | Curative (C) | 2017-04-16 | 2017-04-23 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320016198 | CISPLATIN + RT |
| 320005209 | 320003567 | 1.51 | 93.2 | Palliative (P) | 2015-06-15 | 2015-06-21 | CARBOPLATIN + GEMCITABINE | 02 | N | 320016229 | GEMCARBO |
| 320005210 | 320003568 | 1.64 | null | Curative (C) | 2016-06-10 | 2016-06-21 | Cisplatin + Radiotherapy | N | Y | 320016235 | CISPLATIN + RT |
| 320005211 | 320005623 | 1.74 | 88.5 | Palliative (P) | 2018-07-02 | 2018-08-01 | CETUXIMAB | N | N | 320016253 | CETUXIMAB |
| 320005212 | 320005623 | 1.72 | null | Curative (C) | 2014-03-11 | 2014-03-11 | Cisplatin | N | null | 320016253 | CISPLATIN |
| 320005213 | 320005623 | 1.69 | 84.95 | Palliative (P) | null | 2014-06-21 | CARBOPLATIN + GEMCITABINE | null | null | 320016253 | GEMCARBO |
| 320005214 | 320003571 | 1.75 | 76.7 | Palliative (P) | 2016-08-11 | 2016-08-26 | Liposomal Doxorubicin (Caelyx) | N | N | 320016272 | LIPOSOMAL DOXORUBICIN |
| 320005215 | 320003572 | 1.72 | 92.5 | Palliative (P) | 2018-09-03 | 2018-09-05 | Trial Unspecified | N | N | 320016279 | TRIAL |
| 320005216 | 320003572 | null | 39.4 | Palliative (P) | 2013-09-30 | 2013-10-15 | Carboplatin + Liposomal Doxorubicin | N | null | 320016279 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005217 | 320005626 | 1.87 | 59.2 | Palliative (P) | 2016-12-20 | 2017-01-11 | CISPLATIN + FLUOROURACIL | 2 | null | 320016288 | CISPLATIN + FLUOROURACIL |
| 320005218 | 320003575 | 1.7 | 80.6 | Palliative (P) | 2016-04-11 | 2016-04-13 | Trial Unspecified | N | N | 320016288 | TRIAL |
| 320005219 | 320003575 | 1.51 | 109.8 | Curative (C) | 2016-08-18 | 2016-09-10 | Cisplatin 100 + RT(H&N) 1 day | Y | N | 320016288 | CISPLATIN + RT |
| 320005222 | 320003577 | 1.67 | 73.2 | Neo-adjuvant (N) | 2013-04-27 | 2013-04-27 | CETUXIMAB | 02 | N | 320016363 | CETUXIMAB |
| 320005223 | 320003579 | null | 58.2 | Neo-adjuvant (N) | null | 2018-02-01 | Cisplatin 7 day | null | null | 320016374 | CISPLATIN |
| 320005224 | 320003579 | 1.71 | 121.95 | null | 2017-07-09 | 2017-07-09 | Liposomal Doxorubicin 40mg/m2 | N | N | 320016374 | LIPOSOMAL DOXORUBICIN |
| 320005225 | 320003580 | 1.62 | 59.6 | Palliative (P) | 2017-07-03 | 2017-07-05 | Trial Unspecified | N | null | 320016403 | TRIAL |
| 320005226 | 320003580 | 1.81 | 90.3 | Palliative (P) | 2017-05-23 | 2017-05-23 | CISPLATIN + FLUOROURACIL | 2 | N | 320016403 | CISPLATIN + FLUOROURACIL |
| 320005227 | 320003580 | 1.8 | 97.9 | Adjuvant (A) | 2016-04-08 | 2016-04-08 | Cisplatin 7 day | N | null | 320016403 | CISPLATIN |
| 320005228 | 320003581 | 1.64 | 71.1 | Curative (C) | 2017-07-13 | 2017-08-05 | Cisplatin + Radiotherapy | N | Y | 320016449 | CISPLATIN + RT |
| 320005229 | 320003581 | 1.6 | 73.9 | Adjuvant (A) | 2013-12-06 | 2015-04-12 | CETUXIMAB | 2 | N | 320016449 | CETUXIMAB |
| 320005230 | 320003583 | 1.71 | 59.2 | Palliative (P) | 2017-05-20 | 2017-05-20 | GEMCARBO | 02 | N | 320016473 | GEMCARBO |
| 320005231 | 320005633 | 0 | 67.75 | Adjuvant (A) | 2017-04-15 | 2017-06-22 | Cisplatin + Radiotherapy | N | N | 320016473 | CISPLATIN + RT |
| 320005232 | 320003586 | 1.63 | 76.5 | Palliative (P) | 2017-01-27 | 2017-01-30 | Liposomal Doxorubicin (Caelyx) | 02 | N | 320016498 | LIPOSOMAL DOXORUBICIN |
| 320005233 | 320003587 | 1.6 | 85.2 | Palliative (P) | 2018-04-24 | 2018-04-24 | CARBOPLATIN + GEMCITABINE | 02 | N | 320016530 | GEMCARBO |
| 320005234 | 320003587 | 1.7 | null | Adjuvant (A) | 2016-09-20 | 2016-09-21 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320016530 | CISPLATIN + RT |
| 320005235 | 320003587 | 1.78 | 74.2 | Curative (C) | 2013-10-12 | 2013-10-12 | Cisplatin + Radiotherapy | N | N | 320016530 | CISPLATIN + RT |
| 320005237 | 320003589 | 1.82 | 106.6 | Adjuvant (A) | 2015-09-22 | 2015-10-01 | Cetuximab 7 day (>Cycle 2) | 02 | N | 320016569 | CETUXIMAB |
| 320005238 | 320003589 | 1.71 | 95.9 | Neo-adjuvant (N) | 2017-11-20 | 2017-12-24 | Trial Unspecified | Y | N | 320016569 | TRIAL |
| 320005239 | 320003589 | 1.79 | 89.1 | Adjuvant (A) | 2017-04-17 | 2017-05-13 | Cetuximab 7 day (Cycle 1) | N | Y | 320016569 | CETUXIMAB |
| 320005240 | 320003590 | 1.68 | 60 | Palliative (P) | 2016-03-21 | 2016-03-21 | Carboplatin + Liposomal Doxorubicin | N | N | 320016578 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005241 | 320005636 | 1.54 | 114.2 | Palliative (P) | 2015-11-29 | 2015-12-24 | Liposomal Doxorubicin (Caelyx) | N | N | 320016600 | LIPOSOMAL DOXORUBICIN |
| 320005242 | 320003591 | 1.76 | null | Adjuvant (A) | 2014-06-12 | 2015-03-14 | GEMCARBO | Y | null | 320016613 | GEMCARBO |
| 320005243 | 320003591 | 1.63 | -1 | Curative (C) | 2016-03-27 | 2016-04-03 | Trial Unspecified | 02 | Y | 320016613 | TRIAL |
| 320005244 | 320003592 | 1.85 | 76.4 | Palliative (P) | 2015-04-13 | 2015-10-27 | CISPLATIN + FLUOROURACIL | N | null | 320016622 | CISPLATIN + FLUOROURACIL |
| 320005245 | 320003592 | 1.67 | 70.05 | Palliative (P) | 2015-06-20 | 2015-12-13 | Carboplatin + Liposomal Doxorubicin | 2 | Y | 320016622 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005246 | 320003593 | 1.55 | 57 | Palliative (P) | 2014-03-23 | 2014-04-04 | CETUXIMAB | N | N | 320016641 | CETUXIMAB |
| 320005247 | 320003593 | 1.73 | 79.7 | Disease modification (D) | null | 2013-03-01 | Cisplatin | null | null | 320016641 | CISPLATIN |
| 320005248 | 320003593 | null | 64.9 | Palliative (P) | 2014-02-21 | 2014-02-21 | GemCarbo Days 1+8 | 02 | N | 320016641 | GEMCARBO |
| 320005249 | 320003594 | 1.88 | 61 | Adjuvant (A) | null | 2017-02-28 | CISPLATIN + RT | null | null | 320016658 | CISPLATIN + RT |